157 related articles for article (PubMed ID: 6453139)
21. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
Ponte P; Serrão V; Apetato M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
[TBL] [Abstract][Full Text] [Related]
23. Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA).
Powell FC; Spiegel GT; Muller SA
Mayo Clin Proc; 1984 Aug; 59(8):538-46. PubMed ID: 6748744
[TBL] [Abstract][Full Text] [Related]
24. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
Thomsen K; Hammar H; Molin L; Volden G
Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
[TBL] [Abstract][Full Text] [Related]
25. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
27. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous malignant melanoma appearing during photochemotherapy of mycosis fungoides.
Reseghetti A; Tribbia G; Locati F; Naldi L; Marchesi L
Dermatology; 1994; 189(1):75-7. PubMed ID: 8003794
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study.
Cox NH; Jones SK; Downey DJ; Tuyp EJ; Jay JL; Moseley H; Mackie RM
Br J Dermatol; 1987 Feb; 116(2):145-52. PubMed ID: 3828211
[TBL] [Abstract][Full Text] [Related]
30. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
Tourbier H; Schultz-Ehrenburg U
Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717
[TBL] [Abstract][Full Text] [Related]
31. Transient lymphomatoid papulosis in mycosis fungoides.
Aronsson A; Jonsson N; Tegner E
Acta Derm Venereol; 1982; 62(6):529-31. PubMed ID: 6187163
[TBL] [Abstract][Full Text] [Related]
32. PUVA treatment in mycosis fungoides.
Niemi KM
Dermatologica; 1979; 158(6):462-7. PubMed ID: 467765
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E
Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321
[TBL] [Abstract][Full Text] [Related]
34. Mycosis fungoides presenting as Ofuji's papuloerythroderma.
Hur J; Seong JY; Choi TS; Jang JG; Jang MS; Suh KS; Kim ST
J Eur Acad Dermatol Venereol; 2002 Jul; 16(4):393-6. PubMed ID: 12224701
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy and safety of topical PUVA treatment for refractory lesions of mycosis fungoides].
Yan Y; Xu C; Wang T; Liu J; Liu Y
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):859-62. PubMed ID: 26887519
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
Papadavid E; Antoniou C; Nikolaou V; Siakantaris M; Vassilakopoulos TP; Stratigos A; Stavrianeas N; Katsambas A
Am J Clin Dermatol; 2008; 9(3):169-73. PubMed ID: 18429646
[TBL] [Abstract][Full Text] [Related]
37. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
38. Bullous pemphigoid. Occurrence in a patient with mycosis fungoides receiving PUVA and topical nitrogen mustard therapy.
Patterson JW; Ali M; Murray JC; Hazra TA
Int J Dermatol; 1985 Apr; 24(3):173-6. PubMed ID: 3888880
[TBL] [Abstract][Full Text] [Related]
39. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
40. A rare presentation of erythrodermic mycosis fungoides.
Goyal T; Varshney A
Cutis; 2012 May; 89(5):229-32, 236. PubMed ID: 22768436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
